Pfizer to help 23andMe unravel genetic ties to bowel disease

August 12, 2014 6:01 PM

13 0

Pfizer to help 23andMe unravel genetic ties to bowel disease

(Reuters) - Home genetics company 23andMe on Tuesday said it hopes to uncover gene mutations linked to inflammatory bowel disease (IBD) by enrolling 10,000 people with the hard-to-treat malady and examining DNA from their donated saliva samples.

The privately held company, founded in 2006 by Anne Wojcicki and backed by Google Inc, said U.S. drugmaker Pfizer Inc will support its latest research effort.

Read more

To category page

Loading...